drugset / Trial / NCT05494567
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
RandomizedParallel-groupSingle-blindTreatment
Summary
The investigators will compare the efficacy and safety of tadalafil/solifenacin combination therapy versus tamsulosin/solifenacin combination therapy for the treatment of BPH/OAB in a randomized controlled trial (RCT).
Timeline
- Start
- 2021-11-08
- Primary completion
- 2022-08
- Completion
- 2022-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Solifenacin | Small molecule | 10 mg | — |
| Comparator | Tadalafil | Small molecule | 5 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |